NeuroMetrix (NURO) - Ekuitas Perusahaan

NeuroMetrix, Inc. (NURO) specializes in developing non-invasive Quell systems for the drug-free management of neuropathic pain. This market valuation chart reflects a current figure of 0.01. However, growth potential is constrained by a narrow market niche and possible certification delays for new developments, which, coupled with competition from pharmacology, could negatively impact future sales volumes.

NURO Kapitalisasi Buku NeuroMetrix (04.07.2022 - 11.05.2025)

NeuroMetrix (NURO) - rincian metrik lan laporan keuangan

- rega lan prakiraan konsensus rega:

Bagan owah-owahan rega NeuroMetrix Corporation|NURO - Bagan rega target

- data kapitalisasi pasar:

Nilai pasar NeuroMetrix Inc|NURO - Nilai Total Perusahaan

- data kapitalisasi buku:

Nilai Akuntansi saben Saham NeuroMetrix|NURO - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku neurometrix.com|NURO - Total Aset Perusahaan

- data utang lan likuiditas:

Rasio Utang marang Ekuitas NeuroMetrix, Inc.|NURO - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal NeuroMetrix Inc|NURO - Gunggung utang perusahaan|Utang marang nilai buku NeuroMetrix Inc

Pambiji fundamental:NURO - NeuroMetrix Corporation

The erosion of NeuroMetrix, Inc. (NURO) market share under pressure from consumer gadgets directly impacts the dynamics of net assets, which form the basis of the business valuation. By analyzing the firm's book value of equity, an investor sees the difference between all assets and liabilities, which is critically important during liquidity contractions. Growth in this metric often signals fundamental stability, even if share prices remain stagnant.

Analisis pesaing NeuroMetrix, Inc.